Scientist Profiles

Sally L. Glaser, Ph.D. CEO and Research Scientist Cancer Prevention Institute of California Director, Greater Bay Area Cancer Registry Consulting Associate Professor, Division of Epidemiology, Dept. of Health Research & Policy, Stanford University School of Medicine Member, Stanford Cancer Institute

2201 Walnut Avenue, Suite 300
Fremont, California 94538-2334
E-mail: Sally.Glaser@CPIC.org
Phone: 510-608-5042
Fax: 510-608-5085

Research Interests:

• Using registry data to document and understand patterns of cancer incidence and survival
• Understanding factors leading to the development of and survival after Hodgkin lymphoma
• Understanding factors leading to the development of and survival after breast cancer
• Understanding how Epstein-Barr virus is related to the development of cancers

Hodgkin lymphoma: Dr. Glaser has conducted numerous descriptive studies in the epidemiology of Hodgkin lymphoma (HL). Her analytic work includes a case-control study of reproductive factors for HL in women that yielded analyses of numerous additional risk factors and pertinent methodologic issues. With collaborators, Glaser has evaluated the reliability of Epstein-Barr virus (EBV) detection assays, generating interpretation guidelines to minimize this variation. Her current interests in HL involve genetic determinants of risk and their interaction with environmental factors.

Breast cancer: Dr. Glaser's analytic studies have focused primarily on immune function modulators. These include a population-based study of EBV and risk of breast cancer, and subsequent work with collaborators to develop a comprehensive panel of novel EBV assays to apply to a representative group of breast tumors. In addition, she has pursued the hypothesis that racial/ethnic variation in HL genotypes explains some portion of racial/ethnic variation in breast cancer incidence.

Surveillance: Within the Greater Bay Area Cancer Registry, Dr. Glaser has built a research program dedicated to the insightful use of population-based registry data to inform understanding of site-specific incidence and survival patterns in various populations, particularly those defined by race/ethnicity and socioeconomic status. Current interests include evaluating population demographic trends for their impact on incidence, and examining the influence of the social and built s on incidence and outcomes.

As Director of the Greater Bay Area Cancer Registry, Dr. Glaser is committed to excellence in registry function and preparing for changes facing cancer registration, including expanding data content to include more information on biomarkers, comorbidities and intermediate endpoints such as recurrence.

Selected Research Projects:

Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud P-A, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, Slager SL, Fredericksen ZS, Strong LC, Habermann TM, Link BK, Cerhan JR, Robison LL, Conti DV, Onel K. A genome-wide meta-analysis of nodular sclerosis Hodgkin lymphoma identifies risk loci at 6p21.32.  Blood. 2011; epub.

Clarke CA, Glaser SL, Gomez SL, Wang SS, Keegan TH, Yang J, Chang ET. Lymphoid malignancies in US Asians: incidence rate differences by birthplace and acculturation.  Cancer Epidemiol Biomarkers Prev. 2011; 20:1064-77.

Gomez SL, Glaser SL, McClure LA, Shema SJ, Kealey M, Keegan THM, Satariano WA. The California Neighborhoods Data System: a new resource for examining the impact of neighborhood characteristics on cancer incidence and outcomes in populations. Cancer Causes Control. 2011; 22:631-47.

McLaughlin RH, Clarke CA, Crawley LM, Glaser SL. Are cancer registries unconstitutional? Soc Sci Med. 2010 May;70(9):1295-300. Epub 2010 Feb 12.

Gomez SL, Quach T, Horn-Ross PL, Pham JT, Cockburn M, Chang ET, Keegan TH, Glaser SL, Clarke CA. Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status. Am J Public Health. 2010 Apr 1;100 Suppl 1:S125-31.

Keegan TH, Clarke CA, Chang ET, Shema SJ, Glaser SL. Disparities in survival after Hodgkin lymphoma: a population-based study. Cancer Causes Control. 2009 Jun 26.

Glaser SL, Gulley ML, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Anton-Culver H, Ambinder RA. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer. 2008;123:1499-507.

Glaser SL, Clarke CA, Gomez SL, O'Malley CD, Purdie DM, West DW. Cancer surveillance research: a vital subdiscipline of cancer epidemiology.Cancer Causes Control. 2005;16:1009-19.

All Publications (92)

Education:

Professional Memberships, Professional Activities, and Awards:

CANCER PREVENTION INSTITUTE OF CALIFORNIA:
2009 - present: Chief Executive Officer
2008-2009:        Interim Executive Director
2000-2006:       Director, Surveillance Research, Greater Bay Area Cancer Registry

EXTERNAL:
2007:                 Member, Stanford Cancer Center Survivorship Program
2006 - present: Member, Stanford Cancer Center
2005 - present: Principal Investigator, SEER program; Director, Greater Bay Area Cancer Registry
2005 - present: Member, North American Association of Central Cancer Registries
2005 - present: Consulting Associate Professor, Stanford University, Department of Health Research and Policy
2003-2005:       Co-Principal Investigator, Greater Bay Area Cancer Registry

Web Site Links:
Stanford website for Dr. Glaser:
http://med.stanford.edu/profiles/Sally_Glaser/

Back to Scientist Profiles.